Nutra Pharma Corp (NPHC) Operating Expenses (2010 - 2026)

Nutra Pharma has disclosed Operating Expenses across 17 years of filings, most recently posting $468089.0 for Q2 2026.

• In Q2 2026, Operating Expenses rose 32.24% year-over-year to $468089.0; the TTM figure through Jun 2026 stood at $1.7 million (up 35.61% YoY), while the FY2025 annual figure was $1.7 million, up 47.37% from the prior year.
• Operating Expenses came in at $468089.0 for Q2 2026 at Nutra Pharma, up from $398224.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.2 million in Q4 2022 to a low of $233961.0 in Q4 2023.
• Average Operating Expenses over 5 years is $392749.1, with a median of $342231.5 recorded in 2024.
• Year-over-year, Operating Expenses soared 154.77% in 2022 and slumped 79.92% in 2023.
• Over 5 years, Operating Expenses stood at $1.2 million in 2022, then tumbled by 79.92% to $233961.0 in 2023, then grew by 13.46% to $265455.0 in 2024, then surged by 71.03% to $454007.0 in 2025, then advanced by 3.1% to $468089.0 in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $468089.0 in Q2 2026, $398224.0 in Q1 2026, and $454007.0 in Q4 2025.